Dallas TX 帕金森病临床试验
9项针对 帕金森病的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
招募中2 期
- Neurology Consultants of Dallas PA, Dallas
Motor Network Physiology
招募中
- UT Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
招募中2 期
- Vima Site #063, Dallas
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
招募中3 期
- Texas Neurology PA, Dallas
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
招募中观察性研究
- University of Texas Southwestern Medical Center, Dallas
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
招募中观察性研究欢迎健康志愿者
- UT Southwestern Medical Center, Dallas
Action Regulation Behavioral
招募中欢迎健康志愿者
- University of Texas Southwestern Medical Center, Dallas
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
招募中4 期
- Neurology Consultants of Dallas, PA, Dallas
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
招募中
- University of Texas Southwestern Medical Center, Dallas
其他城市的 帕金森病试验
- New York City, NY23 项研究
- Boston, MA19 项研究
- Cleveland, OH18 项研究
- Minneapolis, MN17 项研究
- Nashville, TN15 项研究
- Philadelphia, PA14 项研究
- San Francisco, CA14 项研究
- New Haven, CT14 项研究
- Charleston, SC13 项研究
- Farmington Hills, MI13 项研究
- Chicago, IL13 项研究
- Miami, FL13 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 癌症（所有类型）37 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 肺癌27 项研究
- 膀胱癌27 项研究
- 子宫内膜癌24 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。